Analysis of in vivo screening data and gene expression data from CAR-T treated relapsed B-ALL cells identified multiple modulators of IFNγR/JAK/STAT signaling as key mediators of CAR-T resistance. Here, IFNGR1 is linked to acute lymphoblastic leukemia.